ACUTE MYELOID LEUKAEMIA (AML)
Clinical trials for ACUTE MYELOID LEUKAEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKAEMIA (AML) trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKAEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Harvard tests AI as Cancer-Detecting partner for doctors
Diagnosis CompletedThis study tested whether artificial intelligence (AI) could help doctors diagnose a rare blood cancer called acute promyelocytic leukemia (APL) more quickly and accurately. Doctors reviewed bone marrow samples with and without AI assistance to see if the technology improved thei…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: NA • Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Diagnosis
Last updated Apr 01, 2026 21:26 UTC
-
Scientists search for hidden cause of leukemia relapse
Knowledge-focused CompletedThis study aimed to understand why some patients with a specific, often treatable type of acute myeloid leukemia (AML) still relapse. Researchers analyzed bone marrow cells from 70 patients to see if certain cells in the bone marrow environment help leukemia cells survive treatme…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:25 UTC